These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 8991095)
21. Analysis of the retrovirus capsid interdomain linker region. Arvidson B; Seeds J; Webb M; Finlay L; Barklis E Virology; 2003 Mar; 308(1):166-77. PubMed ID: 12706100 [TBL] [Abstract][Full Text] [Related]
22. Localization of actin in Moloney murine leukemia virus by immunoelectron microscopy. Nermut MV; Wallengren K; Pager J Virology; 1999 Jul; 260(1):23-34. PubMed ID: 10405353 [TBL] [Abstract][Full Text] [Related]
23. Subcellular localization of recombinant truncated Gag precursor proteins of HIV expressed in Saccharomyces cerevisiae. Biemans R; Thines D; Gheysen D; Rutgers T; Cabezon T AIDS; 1992 Jun; 6(6):541-6. PubMed ID: 1388874 [TBL] [Abstract][Full Text] [Related]
24. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. Ono A; Orenstein JM; Freed EO J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302 [TBL] [Abstract][Full Text] [Related]
26. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Gheysen D; Jacobs E; de Foresta F; Thiriart C; Francotte M; Thines D; De Wilde M Cell; 1989 Oct; 59(1):103-12. PubMed ID: 2676191 [TBL] [Abstract][Full Text] [Related]
27. The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag. Nitta T; Tam R; Kim JW; Fan H mBio; 2011; 2(1):e00341-10. PubMed ID: 21343359 [TBL] [Abstract][Full Text] [Related]
28. Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport. Soneoka Y; Kingsman SM; Kingsman AJ J Virol; 1997 Jul; 71(7):5549-59. PubMed ID: 9188629 [TBL] [Abstract][Full Text] [Related]
29. Passive and active inclusion of host proteins in human immunodeficiency virus type 1 gag particles during budding at the plasma membrane. Hammarstedt M; Garoff H J Virol; 2004 Jun; 78(11):5686-97. PubMed ID: 15140966 [TBL] [Abstract][Full Text] [Related]
30. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). Sandefur S; Smith RM; Varthakavi V; Spearman P J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178 [TBL] [Abstract][Full Text] [Related]
31. Expression of a murine leukemia virus Gag-Escherichia coli RNase HI fusion polyprotein significantly inhibits virus spread. VanBrocklin M; Ferris AL; Hughes SH; Federspiel MJ J Virol; 1997 Apr; 71(4):3312-8. PubMed ID: 9060701 [TBL] [Abstract][Full Text] [Related]
32. RNA sequences in the Moloney murine leukemia virus genome bound by the Gag precursor protein in the yeast three-hybrid system. Evans MJ; Bacharach E; Goff SP J Virol; 2004 Jul; 78(14):7677-84. PubMed ID: 15220442 [TBL] [Abstract][Full Text] [Related]
33. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells. Bouamr F; Garnier L; Rayne F; Verna A; Rebeyrotte N; Cerutti M; Mamoun RZ Virology; 2000 Dec; 278(2):597-609. PubMed ID: 11118382 [TBL] [Abstract][Full Text] [Related]
34. Role of cell cytoskeleton in Mo-MuLV env transport and processing: implications in ts1 neuropathology. Soong MM; Tompkins WA Exp Mol Pathol; 1987 Jun; 46(3):294-311. PubMed ID: 2439368 [TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of interactions between Gag proteins of Rous sarcoma virus. Li X; Yuan B; Goff SP J Virol; 1997 Jul; 71(7):5624-30. PubMed ID: 9188638 [TBL] [Abstract][Full Text] [Related]
37. The HIV-1 Gag precursor Pr55gag synthesized in yeast is myristoylated and targeted to the plasma membrane. Jacobs E; Gheysen D; Thines D; Francotte M; de Wilde M Gene; 1989 Jun; 79(1):71-81. PubMed ID: 2673935 [TBL] [Abstract][Full Text] [Related]
38. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. Accola MA; Strack B; Göttlinger HG J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843 [TBL] [Abstract][Full Text] [Related]
39. Tracking the assembly pathway of human immunodeficiency virus type 1 Gag deletion mutants by immunogold labeling. Wang JJ; Sandefur S; Spearman P; Chiou CT; Chiang PH; Ratner L Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):371-9. PubMed ID: 11759066 [TBL] [Abstract][Full Text] [Related]
40. Defects in virion production caused by mutations affecting the C-terminal portion of the Moloney murine leukemia virus capsid protein. Wang MQ; Goff SP J Virol; 2003 Mar; 77(5):3339-44. PubMed ID: 12584360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]